You are here

Rita Sulahian


Sulahian R, Chen J, Arany Z, et al. SOX15 governs transcription in human stratified epithelia and a subset of esophageal adenocarcinomas. Cell Mol Gastroenterol Hepatol. 2015 Nov 1;1(6):598–609.e6.

Sulahian R, Casey F, Shen J, et al. An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer. Oncogene. 2014 Dec 4;33(49):5637–5648.

Sulahian R, Cleaver O, Huang LJ. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia. Blood. 2009 May 21;113(21):5287–5297.

Rita Sulahian, Ph.D.

Rita Sulahian is a scientist II working in the Cancer Program at the Broad Institute of MIT and Harvard. Her research (under the direction of William Hahn) is part of the KRAS initiative, in which the main effort is targeting the oncogene KRAS from novel angles.

Sulahian is also a BE Communication Lab Fellow as part of a new Broad Institute initiative for effective written, oral, and visual communication support for all Broad Institute members. This initiative is led by the MIT Biological Engineering Communication Lab.

Prior to joining the Broad Institute in February 2015, Sulahian investigated the role of ubiquination of EpoR at the University of Texas Southwestern Medical Center in Dallas. During her postdoctoral fellowship at the Dana-Farber Cancer Institute in Boston, she focused on the role of epigenomics and transcriptional regulation of esophageal and gastro-intestinal cells in normal and malignant contexts.

Sulahian holds a Ph.D. in genetics and development from UT Southwestern Medical Center as well as B.S. and M.S. degrees in biology from the American University of Beirut.

Contact Rita Sulahian via email at

June 2016